Cancer Insurance

Global Cancer Insurance Market to Reach US$142.0 Billion by 2030

The global market for Cancer Insurance estimated at US$80.9 Billion in the year 2024, is expected to reach US$142.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Individual Insurance Plan, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$87.1 Billion by the end of the analysis period. Growth in the Supplement Insurance Plan segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.3 Billion While China is Forecast to Grow at 9.4% CAGR

The Cancer Insurance market in the U.S. is estimated at US$21.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.5 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Cancer Insurance Market – Key Trends & Drivers Summarized

Why Is Cancer Insurance Gaining Strategic Importance in Personal Financial Planning and Health Risk Protection?
Cancer insurance is becoming an essential layer of financial protection in response to the rising global burden of cancer and the high out-of-pocket costs associated with its diagnosis, treatment, and long-term management. Unlike standard health insurance, cancer-specific policies are designed to provide lump-sum payouts or reimbursements that can be used flexibly—for medical expenses, travel for treatment, loss of income, or supportive care. As cancer incidence increases across both developed and emerging markets, individuals and families are recognizing the value of specialized insurance to mitigate the financial volatility of a critical illness event.

The unpredictable nature of cancer diagnosis, treatment duration, and therapy costs—including chemotherapy, radiation, immunotherapy, and targeted drugs—underscores the relevance of standalone or supplemental cancer insurance policies. Employers, insurers, and financial advisors are increasingly recommending cancer insurance as part of comprehensive health and wellness planning, especially for high-risk individuals, aging populations, or those with limited access to universal healthcare.

How Are Product Innovation and Digital Distribution Expanding Access to Cancer Insurance Solutions?
Insurers are launching modular and tiered cancer insurance products that cater to varied demographic needs, offering coverage based on cancer stage, type, or recurrence status. Policies now include early diagnosis benefits, income replacement, and coverage for non-medical expenses such as home modifications and palliative care. Some plans also integrate second-opinion services, tele-oncology support, and wellness programs for cancer prevention and survivorship.

Digital platforms are driving product discovery, quote generation, and policy issuance with greater transparency and speed. Mobile apps, online calculators, and AI-based risk assessment tools are enhancing customer engagement and enabling targeted marketing for high-risk groups. Embedded insurance offerings—bundled with credit cards, digital wallets, or employer benefit programs—are further expanding reach, particularly in underpenetrated segments. These innovations are lowering barriers to entry and aligning cancer insurance with evolving consumer expectations around personalization and convenience.

Where Is Demand for Cancer Insurance Rising and Which Market Segments Are Driving Uptake?
North America and parts of Europe remain mature markets for cancer insurance, supported by high healthcare costs and gaps in standard insurance plans. In the U.S., where cancer treatment expenses can easily exceed six figures, supplemental cancer policies are commonly marketed to middle-income and retiree demographics. Europe sees moderate uptake through employer-sponsored plans and voluntary top-up coverage models.

Asia-Pacific is emerging as a high-growth region, driven by rapidly increasing cancer incidence, rising healthcare awareness, and underinsurance in markets such as India, China, Indonesia, and the Philippines. Insurers in these regions are targeting middle-class consumers, gig workers, and rural populations with affordable, simplified products distributed via bancassurance, mobile networks, and fintech platforms. Demand is especially strong among first-time policyholders seeking low-premium protection against high-impact health events.

What Is Fueling the Global Growth of the Cancer Insurance Market?
The global cancer insurance market is expanding on the back of rising cancer prevalence, increasing financial literacy, and the growing recognition of insurance as a tool for health risk management. Aging populations, urban lifestyle shifts, and environmental risk factors are driving cancer rates upward, while medical inflation continues to outpace income growth in many regions. As a result, insurers are positioning cancer-specific products as critical safeguards within broader health and financial security portfolios.

Strategic alliances between insurers, hospitals, and digital health platforms are enhancing claims processing, early detection initiatives, and treatment navigation—strengthening the value proposition of cancer insurance. Regulatory support for microinsurance, product standardization, and digital onboarding is also enabling penetration in price-sensitive markets. As cancer becomes a long-term health challenge with significant economic implications, a defining question shapes the market’s trajectory: Can cancer insurance evolve into an inclusive, responsive, and data-driven solution that delivers meaningful financial protection—while supporting prevention, early detection, and survivorship in a rapidly changing healthcare landscape?

SCOPE OF STUDY:

The report analyzes the Cancer Insurance market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Insurance Plan (Individual Plan, Supplement Plan, Critical Illness Plan); Gender (Male, Female)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

• Aegon N.V.
• Aflac Incorporated
• Allianz SE
• American Fidelity Assurance Company
• Anthem, Inc.
• Aviva plc
• AXA S.A.
• Bajaj Allianz General Insurance
• Bharti AXA General Insurance
• Blue Cross Blue Shield Association
• Cigna Corporation
• Colonial Life & Accident Insurance
• Desjardins Group
• ICICI Prudential Life Insurance
• Kaiser Permanente
• Liberty Mutual Insurance
• ManipalCigna Health Insurance
• Max Life Insurance Company Limited
• MetLife, Inc.
• Mutual of Omaha Insurance Company

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.